Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 8;20(1):219.
doi: 10.3390/ijms20010219.

Acute Myeloid Leukemia Affects Mouse Sperm Parameters, Spontaneous Acrosome Reaction, and Fertility Capacity

Affiliations

Acute Myeloid Leukemia Affects Mouse Sperm Parameters, Spontaneous Acrosome Reaction, and Fertility Capacity

Yulia Michailov et al. Int J Mol Sci. .

Abstract

Leukemia is one of the most common cancers in patients of reproductive age. It is well known that chemotherapy, used as anti-cancer therapy, adversely affects male fertility. Moreover, the negative effect of leukemia on sperm quality, even before chemotherapy treatment, has been reported. However, the mechanisms behind this disease's effect on sperm quality remains unknown. In this study, we examine the direct effect of leukemia and chemotherapy alone and in combination on sperm parameters and male fertility. For this, we developed an acute myeloid leukemia (AML) mouse model (mice were treated with AML cells C1498 and developed leukemia); these mice then received cytarabine chemotherapy. Our findings reveal a significant reduction in sperm concentration and motility and a significant increase in abnormal morphology and spontaneous acrosome reaction of the sperm following AML and chemotherapy treatment, alone and in combination. We also found a reduction in male fertility and the number of delivered offspring. Our results support previous findings that AML impairs sperm parameters and show for the first time that AML increases spontaneous acrosome reaction and decreases male fertility capacity and number of offspring.

Keywords: acrosome reaction; acute myeloid leukemia; male infertility; sperm parameters; testis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Effect of AML cells, cytarabine, and the combination of both on mice survival: Adult C57/black mice were injected with PBS (control), C1498 cells (C1498), cytarabine (Cyt), or with a combination of both (Cyt + C1498). The survival of mice was evaluated 2–8 weeks after injection (see the Methods) in intervals of one week. The results are representative of four independent experiments with 10 mice in each group.
Figure 2
Figure 2
Effect of AML cells, cytarabine, and the combination of both on sperm concentration: Mice were treated as described in Figure 1. Sperm were extracted from the epididymis 1–4 weeks post-treatment. Sperm concentration was evaluated using a Makler counting chamber and determined according to WHO criteria. The results are representative of three independent experiments with 8–10 mice in each group. * Significant compared to control. @ Significant for Cyt + C1498 compared to Cyt. *, @ p < 0.05; **, @@ p < 0.01; ***, @@@ p < 0.001.
Figure 3
Figure 3
Effect of AML cells, cytarabine, and the combination of both on sperm motility: Mice were treated as described in Figure 1. Sperm were extracted from the epididymis 1–4 weeks post-treatment. Sperm motility/immotility was evaluated using a Makler counting chamber and determined as a percentage of total sperm according to WHO criteria. The results are representative of three independent experiments with 8–10 mice in each group. * Significant compared to control. $ Significant for Cyt + C1498 compared to C1498. *, $ p < 0.05; **, $$ p <0.01; ***, $$$ p < 0.001.
Figure 4
Figure 4
Effect of AML cells, cytarabine, and the combination of both on sperm morphology: Mice were treated as described in Figure 1. Sperm were extracted from the epididymis three weeks post-treatment. Sperm morphology was evaluated following staining with Diff-Quick stain (magnification of ×1000) (A). Cells were divided into different types of morphology: (I) normal morphology, (II) abnormal neck, (III) abnormal tail, (IV) abnormal head according to WHO criteria. The percentage of sperm with normal morphology was calculated (B). The results are representative of three independent experiment with three mice in each group. * Significant compared to control. $ Significant of Cyt + C1498 compared to C1498. $$ p < 0.01; *** p < 0.001.
Figure 5
Figure 5
Effect of AML cells, cytarabine, and the combination of both compared to control (CT) on sperm spontaneous acrosome reaction: Mice were treated as described in Figure 1. Three weeks post-treatment, sperm were extracted from the epididymis and stained by fluorescein (FITC) staining (A). Acrosome reacted (without green staining) and non-reacted sperm (with green staining) were counted (A), and the percent of sperm that underwent spontaneous acrosome reaction was calculated (B). The results are representative of three independent experiment with four mice in each group. * Significant compared to control. *** p < 0.001.
Figure 6
Figure 6
Effect of AML cells, cytarabine, and the combination of both on mice fertility and number of offspring: Mice were treated as described in Figure 1. Two weeks post-treatment, a single male from each group was mated with two females. After two weeks, the females were separated each to a single cage. The number of pregnant females (A) and number of offspring from each female were counted after five weeks (B). The results are representative of three independent experiments with four mice in each group. * Significant compared to control. * p < 0.05; ** p < 0.01; *** p < 0.001.

Similar articles

Cited by

References

    1. Tournaye H., Goossens E., Verheyen G., Frederickx V., De Block G., Devroey P., Van Steirteghem A. Preserving the reproductive potential of men and boys with cancer: Current concepts and future prospects. Hum. Reprod. Update. 2004;10:525–532. doi: 10.1093/humupd/dmh038. - DOI - PubMed
    1. Bramswig J.H., Heimes U., Heiermann E., Schlegel W., Nieschlag E., Schellong G. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin’s disease during childhood or adolescence. Cancer. 1990;65:1298–1302. - PubMed
    1. Siimes M.A., Rautonen J. Small testicles with impaired production of sperm in adult male survivors of childhood malignancies. Cancer. 1990;65:1303–1306. doi: 10.1002/1097-0142(19900315)65:6<1303::AID-CNCR2820650608>3.0.CO;2-D. - DOI - PubMed
    1. Heikens J., Behrendt H., Adriaanse R., Berghout A. Irreversible gonadal damage in male survivors of pediatric Hodgkin’s disease. Cancer. 1996;78:2020–2024. doi: 10.1002/(SICI)1097-0142(19961101)78:9<2020::AID-CNCR25>3.0.CO;2-Y. - DOI - PubMed
    1. Nurmio M., Keros V., Lahteenmaki P., Salmi T., Kallajoki M., Jahnukainen K. Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility. J. Clin. Endocrinol. Metab. 2009;94:2119–2122. doi: 10.1210/jc.2009-0060. - DOI - PubMed